Farallon Capital Management LLC Ventyx Biosciences, Inc. Transaction History
Farallon Capital Management LLC
- $19.9 Billion
- Q3 2024
A detailed history of Farallon Capital Management LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 3,170,000 shares of VTYX stock, worth $7.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,170,000
Previous 3,170,000
-0.0%
Holding current value
$7.1 Million
Previous $7.32 Million
5.63%
% of portfolio
0.03%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding VTYX
# of Institutions
125Shares Held
52.9MCall Options Held
35.3KPut Options Held
83K-
Deerfield Management Company, L.P. (Series C) New York, NY6.72MShares$15 Million0.27% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$10.7 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.46MShares$9.98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$7.77 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$6.94 Million0.58% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $127M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...